The Current Ratio as of November 2025 (TTM) for Advanced Proteome Therapeutics Corporation (APTCF) is 0.50

According to Advanced Proteome Therapeutics Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 0.50. This represents a change of 7.41% compared to the average of 0.46 of the last 4 quarters.

Advanced Proteome Therapeutics Corporation (APTCF) Historical Current Ratio (quarterly & annually)

How has APTCF Current Ratio performed in the past?

The mean historical Current Ratio of Advanced Proteome Therapeutics Corporation over the last ten years is 0.54. The current 0.50 Current Ratio has changed 9.11% with respect to the historical average. Over the past ten years (40 quarters), APTCF's Current Ratio was at its highest in in the October 2014 quarter at 1.89. The Current Ratio was at its lowest in in the July 2020 quarter at 0.01.

Advanced Proteome Therapeutics Corporation (APTCF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Advanced Proteome Therapeutics Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Advanced Proteome Therapeutics Corporation (APTCF) Average Current Ratio

How has APTCF Current Ratio performed in the past?

The current Current Ratio of Advanced Proteome Therapeutics Corporation (APTCF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Advanced Proteome Therapeutics Corporation (APTCF) Current Ratio vs. Peers

How is APTCF’s Current Ratio compared to its peers?

Advanced Proteome Therapeutics Corporation’s Current Ratio is greater than MedMen Enterprises Inc. (0.49), less than Eden Empire Inc. (0.54), less than TRACON Pharmaceuticals, Inc. (0.89), greater than RedHawk Holdings Corp. (0.29), greater than Predictive Technology Group, Inc. (0.37), greater than Aladdin Healthcare Technologies SE (0.11), less than Hemogenyx Pharmaceuticals Plc (0.72), less than TuHURA Biosciences, Inc. (0.83), less than Pivotal Therapeutics Inc. (0), less than Propanc Biopharma, Inc. (2.45),

Build a custom stock screener for Advanced Proteome Therapeutics Corporation (APTCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Advanced Proteome Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Advanced Proteome Therapeutics Corporation (APTCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Advanced Proteome Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.